Medtech start-up brings sustainable disinfection solution to Australia
An innovative, sustainable disinfection technology that uses UV-C light to disinfect ultrasound probes and cables is now available in Australia.
In partnership with Germitec, MediSound has brought the Hypernova Chronos to the Australian market. The technology uses UV-C light in place of chemical corrosives and irritants, which prolongs the life of ultrasound probes and significantly improves safety for the patient and ultrasound technician.
“This technology will transform how we deliver ultrasound services for the benefit of both patients and healthcare providers,” Southwell said.
“We are excited to bring this technology to Australia and to be partnering with Germitec to deliver the world’s most sophisticated high-level disinfection systems.”
With in-built electronic records management and rapid processing, Chronos mobile units are designed for busy healthcare departments offering point-of-care (bedside) ultrasound services.
“We felt strongly that, from both a safety and environmental perspective, current approaches to high-level disinfection were inadequate,” Co-founder Laiken Clarke said.
“Our research led us to UVC-HLD technology, and we immediately recognised its potential to deliver a higher standard of patient care.
“One thing 2020 has shown us is that we need to carefully re-evaluate the risks of cross-contamination when delivering ultrasound diagnostic services. We’ve brought to market a system that can high-level disinfect ultrasound probe and cable in only 90 seconds, enabling technicians to see more patients and reduce waiting times, while reducing chemical exposure and environmental waste. That’s a compelling proposition that is unmatched in the market.”
MediSound has partnered with numerous clinics and hospitals across Australia to deliver the technology.
“The feedback that we have received so far has been exceptional,” Southwell added.
“The technology and the efficiency of the system allows healthcare professionals to see more patients and ensure that those patients have a significantly reduced risk of hospital-acquired infections. At a time when hospitals globally have been under incredible strain with COVID-19, being able to offer a faster and safer alternative to chemical-based disinfection is hugely rewarding.”
Germitec CEO Clement Deshays said, “Chronos is an innovation with the potential to make a significant impact in reducing cross-infection and improves the ultrasound examination environment at the patient’s bedside, in particular for ultrasound-guided procedures and pulmonary ultrasound examinations in Emergency, Intensive Care or Resuscitation.”
The Hypernova Chronis has been nominated for Best Medical Device at the prestigious 2020 Prix Galien awards.
Three Australian small-cap and start-up executives give their take on what we might see from the...
QUT PhD data science researcher Ahmed Alkenani has developed a chatbot that can identify multiple...
Developed as a result of extensive research at Monash University, the platform uses messages,...